GO:0035019 | somatic stem cell maintenance | 1.56e-04 | 1.00e+00 | 6.687 | 2 | 6 | 40 |
GO:0019901 | protein kinase binding | 3.45e-04 | 1.00e+00 | 4.285 | 3 | 18 | 317 |
GO:0008013 | beta-catenin binding | 3.53e-04 | 1.00e+00 | 6.102 | 2 | 9 | 60 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0023057 | negative regulation of signaling | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0072376 | protein activation cascade | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0051435 | BH4 domain binding | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0042483 | negative regulation of odontogenesis | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 1 | 2 |
GO:0009798 | axis specification | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 1 | 2 |
GO:0060913 | cardiac cell fate determination | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 1 | 3 |
GO:0030027 | lamellipodium | 1.52e-03 | 1.00e+00 | 5.043 | 2 | 7 | 125 |
GO:0018108 | peptidyl-tyrosine phosphorylation | 1.69e-03 | 1.00e+00 | 4.964 | 2 | 4 | 132 |
GO:0005737 | cytoplasm | 1.72e-03 | 1.00e+00 | 1.714 | 6 | 124 | 3767 |
GO:0038127 | ERBB signaling pathway | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 4 |
GO:0019887 | protein kinase regulator activity | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 4 |
GO:0005515 | protein binding | 2.21e-03 | 1.00e+00 | 1.260 | 7 | 198 | 6024 |
GO:0001714 | endodermal cell fate specification | 2.42e-03 | 1.00e+00 | 8.687 | 1 | 1 | 5 |
GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process | 2.42e-03 | 1.00e+00 | 8.687 | 1 | 2 | 5 |
GO:0044212 | transcription regulatory region DNA binding | 2.73e-03 | 1.00e+00 | 4.616 | 2 | 17 | 168 |
GO:0030858 | positive regulation of epithelial cell differentiation | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 6 |
GO:0050847 | progesterone receptor signaling pathway | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 2 | 6 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 6 |
GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 3.39e-03 | 1.00e+00 | 8.201 | 1 | 2 | 7 |
GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development | 3.39e-03 | 1.00e+00 | 8.201 | 1 | 1 | 7 |
GO:0071354 | cellular response to interleukin-6 | 3.39e-03 | 1.00e+00 | 8.201 | 1 | 2 | 7 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 3.39e-03 | 1.00e+00 | 8.201 | 1 | 2 | 7 |
GO:0061099 | negative regulation of protein tyrosine kinase activity | 3.39e-03 | 1.00e+00 | 8.201 | 1 | 1 | 7 |
GO:0045670 | regulation of osteoclast differentiation | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 2 | 8 |
GO:0007172 | signal complex assembly | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 8 |
GO:0060396 | growth hormone receptor signaling pathway | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 8 |
GO:0045667 | regulation of osteoblast differentiation | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 1 | 9 |
GO:0031953 | negative regulation of protein autophosphorylation | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 1 | 9 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 1 | 9 |
GO:0035413 | positive regulation of catenin import into nucleus | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 2 | 10 |
GO:0031274 | positive regulation of pseudopodium assembly | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 2 | 10 |
GO:0030877 | beta-catenin destruction complex | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 2 | 10 |
GO:0031116 | positive regulation of microtubule polymerization | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 1 | 11 |
GO:0051010 | microtubule plus-end binding | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 1 | 11 |
GO:0017166 | vinculin binding | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 1 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 4 | 11 |
GO:0045295 | gamma-catenin binding | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 12 |
GO:0032886 | regulation of microtubule-based process | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 12 |
GO:0035198 | miRNA binding | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 12 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 3 | 13 |
GO:0044295 | axonal growth cone | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 1 | 13 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 2 | 13 |
GO:0043409 | negative regulation of MAPK cascade | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 2 | 13 |
GO:0035371 | microtubule plus-end | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 1 | 14 |
GO:0034614 | cellular response to reactive oxygen species | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 2 | 14 |
GO:0001824 | blastocyst development | 7.26e-03 | 1.00e+00 | 7.102 | 1 | 2 | 15 |
GO:0007026 | negative regulation of microtubule depolymerization | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 16 |
GO:0046716 | muscle cell cellular homeostasis | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 16 |
GO:0043274 | phospholipase binding | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 16 |
GO:0051276 | chromosome organization | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 2 | 16 |
GO:0031122 | cytoplasmic microtubule organization | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 1 | 18 |
GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity | 9.19e-03 | 1.00e+00 | 6.761 | 1 | 2 | 19 |
GO:0008283 | cell proliferation | 1.00e-02 | 1.00e+00 | 3.651 | 2 | 14 | 328 |
GO:0048041 | focal adhesion assembly | 1.01e-02 | 1.00e+00 | 6.616 | 1 | 1 | 21 |
GO:0009954 | proximal/distal pattern formation | 1.01e-02 | 1.00e+00 | 6.616 | 1 | 1 | 21 |
GO:0016575 | histone deacetylation | 1.01e-02 | 1.00e+00 | 6.616 | 1 | 3 | 21 |
GO:0000281 | mitotic cytokinesis | 1.01e-02 | 1.00e+00 | 6.616 | 1 | 2 | 21 |
GO:0008285 | negative regulation of cell proliferation | 1.16e-02 | 1.00e+00 | 3.545 | 2 | 10 | 353 |
GO:0045296 | cadherin binding | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 3 | 24 |
GO:0005654 | nucleoplasm | 1.17e-02 | 1.00e+00 | 2.514 | 3 | 64 | 1082 |
GO:0007155 | cell adhesion | 1.26e-02 | 1.00e+00 | 3.481 | 2 | 5 | 369 |
GO:0007498 | mesoderm development | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 1 | 26 |
GO:0048754 | branching morphogenesis of an epithelial tube | 1.30e-02 | 1.00e+00 | 6.254 | 1 | 1 | 27 |
GO:0005875 | microtubule associated complex | 1.35e-02 | 1.00e+00 | 6.201 | 1 | 1 | 28 |
GO:0071897 | DNA biosynthetic process | 1.35e-02 | 1.00e+00 | 6.201 | 1 | 1 | 28 |
GO:0070830 | tight junction assembly | 1.35e-02 | 1.00e+00 | 6.201 | 1 | 1 | 28 |
GO:0030032 | lamellipodium assembly | 1.40e-02 | 1.00e+00 | 6.151 | 1 | 1 | 29 |
GO:0005913 | cell-cell adherens junction | 1.40e-02 | 1.00e+00 | 6.151 | 1 | 3 | 29 |
GO:0009953 | dorsal/ventral pattern formation | 1.50e-02 | 1.00e+00 | 6.055 | 1 | 2 | 31 |
GO:0007094 | mitotic spindle assembly checkpoint | 1.50e-02 | 1.00e+00 | 6.055 | 1 | 3 | 31 |
GO:0033077 | T cell differentiation in thymus | 1.59e-02 | 1.00e+00 | 5.964 | 1 | 1 | 33 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.60e-02 | 1.00e+00 | 3.298 | 2 | 30 | 419 |
GO:0001942 | hair follicle development | 1.69e-02 | 1.00e+00 | 5.879 | 1 | 2 | 35 |
GO:0034446 | substrate adhesion-dependent cell spreading | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 2 | 36 |
GO:0048538 | thymus development | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 2 | 36 |
GO:0051781 | positive regulation of cell division | 1.88e-02 | 1.00e+00 | 5.723 | 1 | 1 | 39 |
GO:0005881 | cytoplasmic microtubule | 1.93e-02 | 1.00e+00 | 5.687 | 1 | 1 | 40 |
GO:0045785 | positive regulation of cell adhesion | 1.93e-02 | 1.00e+00 | 5.687 | 1 | 2 | 40 |
GO:0004715 | non-membrane spanning protein tyrosine kinase activity | 2.02e-02 | 1.00e+00 | 5.616 | 1 | 3 | 42 |
GO:0031124 | mRNA 3'-end processing | 2.02e-02 | 1.00e+00 | 5.616 | 1 | 2 | 42 |
GO:0006369 | termination of RNA polymerase II transcription | 2.16e-02 | 1.00e+00 | 5.517 | 1 | 2 | 45 |
GO:0016328 | lateral plasma membrane | 2.21e-02 | 1.00e+00 | 5.485 | 1 | 3 | 46 |
GO:0006921 | cellular component disassembly involved in execution phase of apoptosis | 2.26e-02 | 1.00e+00 | 5.454 | 1 | 2 | 47 |
GO:0045732 | positive regulation of protein catabolic process | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 1 | 50 |
GO:0060041 | retina development in camera-type eye | 2.45e-02 | 1.00e+00 | 5.336 | 1 | 2 | 51 |
GO:0051028 | mRNA transport | 2.50e-02 | 1.00e+00 | 5.308 | 1 | 4 | 52 |
GO:0009611 | response to wounding | 2.50e-02 | 1.00e+00 | 5.308 | 1 | 5 | 52 |
GO:0001725 | stress fiber | 2.64e-02 | 1.00e+00 | 5.227 | 1 | 4 | 55 |
GO:0005643 | nuclear pore | 2.73e-02 | 1.00e+00 | 5.176 | 1 | 11 | 57 |
GO:0006406 | mRNA export from nucleus | 2.92e-02 | 1.00e+00 | 5.078 | 1 | 4 | 61 |
GO:0019903 | protein phosphatase binding | 2.97e-02 | 1.00e+00 | 5.055 | 1 | 2 | 62 |
GO:0000776 | kinetochore | 3.02e-02 | 1.00e+00 | 5.031 | 1 | 5 | 63 |
GO:0007409 | axonogenesis | 3.11e-02 | 1.00e+00 | 4.986 | 1 | 2 | 65 |
GO:0010468 | regulation of gene expression | 3.25e-02 | 1.00e+00 | 4.921 | 1 | 2 | 68 |
GO:0034329 | cell junction assembly | 3.25e-02 | 1.00e+00 | 4.921 | 1 | 3 | 68 |
GO:0032587 | ruffle membrane | 3.35e-02 | 1.00e+00 | 4.879 | 1 | 3 | 70 |
GO:0042826 | histone deacetylase binding | 3.44e-02 | 1.00e+00 | 4.839 | 1 | 4 | 72 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 3.54e-02 | 1.00e+00 | 4.799 | 1 | 4 | 74 |
GO:0060070 | canonical Wnt signaling pathway | 3.58e-02 | 1.00e+00 | 4.780 | 1 | 4 | 75 |
GO:0005634 | nucleus | 3.60e-02 | 1.00e+00 | 1.176 | 5 | 159 | 4559 |
GO:0001822 | kidney development | 3.73e-02 | 1.00e+00 | 4.723 | 1 | 3 | 78 |
GO:0007229 | integrin-mediated signaling pathway | 3.73e-02 | 1.00e+00 | 4.723 | 1 | 3 | 78 |
GO:0016020 | membrane | 3.85e-02 | 1.00e+00 | 1.879 | 3 | 46 | 1681 |
GO:0004713 | protein tyrosine kinase activity | 3.91e-02 | 1.00e+00 | 4.651 | 1 | 3 | 82 |
GO:0009653 | anatomical structure morphogenesis | 3.96e-02 | 1.00e+00 | 4.634 | 1 | 2 | 83 |
GO:0009952 | anterior/posterior pattern specification | 3.96e-02 | 1.00e+00 | 4.634 | 1 | 4 | 83 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 4.10e-02 | 1.00e+00 | 4.582 | 1 | 8 | 86 |
GO:0005923 | tight junction | 4.10e-02 | 1.00e+00 | 4.582 | 1 | 2 | 86 |
GO:0006936 | muscle contraction | 4.15e-02 | 1.00e+00 | 4.566 | 1 | 3 | 87 |
GO:0000187 | activation of MAPK activity | 4.29e-02 | 1.00e+00 | 4.517 | 1 | 3 | 90 |
GO:0007010 | cytoskeleton organization | 4.33e-02 | 1.00e+00 | 4.501 | 1 | 4 | 91 |
GO:0006928 | cellular component movement | 4.33e-02 | 1.00e+00 | 4.501 | 1 | 3 | 91 |
GO:0001649 | osteoblast differentiation | 4.38e-02 | 1.00e+00 | 4.485 | 1 | 5 | 92 |
GO:0005178 | integrin binding | 4.57e-02 | 1.00e+00 | 4.424 | 1 | 4 | 96 |
GO:0008360 | regulation of cell shape | 4.89e-02 | 1.00e+00 | 4.322 | 1 | 4 | 103 |
GO:0005938 | cell cortex | 4.94e-02 | 1.00e+00 | 4.308 | 1 | 5 | 104 |
GO:0030308 | negative regulation of cell growth | 5.22e-02 | 1.00e+00 | 4.227 | 1 | 6 | 110 |
GO:0006461 | protein complex assembly | 5.27e-02 | 1.00e+00 | 4.214 | 1 | 4 | 111 |
GO:0030529 | ribonucleoprotein complex | 5.31e-02 | 1.00e+00 | 4.201 | 1 | 5 | 112 |
GO:0007050 | cell cycle arrest | 5.87e-02 | 1.00e+00 | 4.055 | 1 | 5 | 124 |
GO:0030335 | positive regulation of cell migration | 6.00e-02 | 1.00e+00 | 4.020 | 1 | 5 | 127 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 6.05e-02 | 1.00e+00 | 4.009 | 1 | 11 | 128 |
GO:0016477 | cell migration | 6.05e-02 | 1.00e+00 | 4.009 | 1 | 4 | 128 |
GO:0007165 | signal transduction | 6.72e-02 | 1.00e+00 | 2.184 | 2 | 13 | 907 |
GO:0008017 | microtubule binding | 6.92e-02 | 1.00e+00 | 3.809 | 1 | 2 | 147 |
GO:0042981 | regulation of apoptotic process | 7.06e-02 | 1.00e+00 | 3.780 | 1 | 4 | 150 |
GO:0006974 | cellular response to DNA damage stimulus | 7.10e-02 | 1.00e+00 | 3.770 | 1 | 7 | 151 |
GO:0000398 | mRNA splicing, via spliceosome | 7.69e-02 | 1.00e+00 | 3.651 | 1 | 15 | 164 |
GO:0006355 | regulation of transcription, DNA-templated | 7.95e-02 | 1.00e+00 | 2.047 | 2 | 43 | 997 |
GO:0016607 | nuclear speck | 8.06e-02 | 1.00e+00 | 3.582 | 1 | 12 | 172 |
GO:0005667 | transcription factor complex | 8.19e-02 | 1.00e+00 | 3.558 | 1 | 17 | 175 |
GO:0031625 | ubiquitin protein ligase binding | 8.33e-02 | 1.00e+00 | 3.533 | 1 | 5 | 178 |
GO:0044822 | poly(A) RNA binding | 8.79e-02 | 1.00e+00 | 1.964 | 2 | 50 | 1056 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 8.82e-02 | 1.00e+00 | 3.446 | 1 | 5 | 189 |
GO:0005829 | cytosol | 1.05e-01 | 1.00e+00 | 1.308 | 3 | 86 | 2496 |
GO:0008380 | RNA splicing | 1.06e-01 | 1.00e+00 | 3.176 | 1 | 22 | 228 |
GO:0008134 | transcription factor binding | 1.12e-01 | 1.00e+00 | 3.090 | 1 | 18 | 242 |
GO:0000166 | nucleotide binding | 1.19e-01 | 1.00e+00 | 2.992 | 1 | 13 | 259 |
GO:0043065 | positive regulation of apoptotic process | 1.23e-01 | 1.00e+00 | 2.943 | 1 | 7 | 268 |
GO:0005743 | mitochondrial inner membrane | 1.27e-01 | 1.00e+00 | 2.895 | 1 | 6 | 277 |
GO:0019899 | enzyme binding | 1.27e-01 | 1.00e+00 | 2.895 | 1 | 9 | 277 |
GO:0005856 | cytoskeleton | 1.33e-01 | 1.00e+00 | 2.824 | 1 | 9 | 291 |
GO:0005813 | centrosome | 1.48e-01 | 1.00e+00 | 2.660 | 1 | 7 | 326 |
GO:0015031 | protein transport | 1.54e-01 | 1.00e+00 | 2.595 | 1 | 11 | 341 |
GO:0003723 | RNA binding | 1.55e-01 | 1.00e+00 | 2.591 | 1 | 18 | 342 |
GO:0043565 | sequence-specific DNA binding | 1.56e-01 | 1.00e+00 | 2.574 | 1 | 11 | 346 |
GO:0005925 | focal adhesion | 1.65e-01 | 1.00e+00 | 2.493 | 1 | 9 | 366 |
GO:0008284 | positive regulation of cell proliferation | 1.71e-01 | 1.00e+00 | 2.431 | 1 | 10 | 382 |
GO:0045892 | negative regulation of transcription, DNA-templated | 1.84e-01 | 1.00e+00 | 2.319 | 1 | 24 | 413 |
GO:0006468 | protein phosphorylation | 2.03e-01 | 1.00e+00 | 2.163 | 1 | 10 | 460 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.10e-01 | 1.00e+00 | 2.108 | 1 | 24 | 478 |
GO:0048471 | perinuclear region of cytoplasm | 2.20e-01 | 1.00e+00 | 2.037 | 1 | 8 | 502 |
GO:0006915 | apoptotic process | 2.40e-01 | 1.00e+00 | 1.892 | 1 | 12 | 555 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 2.46e-01 | 1.00e+00 | 1.854 | 1 | 37 | 570 |
GO:0010467 | gene expression | 2.83e-01 | 1.00e+00 | 1.623 | 1 | 45 | 669 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 2.94e-01 | 1.00e+00 | 1.560 | 1 | 39 | 699 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 3.26e-01 | 1.00e+00 | 1.385 | 1 | 41 | 789 |
GO:0070062 | extracellular vesicular exosome | 3.29e-01 | 1.00e+00 | 0.780 | 2 | 57 | 2400 |
GO:0005887 | integral component of plasma membrane | 3.59e-01 | 1.00e+00 | 1.214 | 1 | 10 | 888 |
GO:0005886 | plasma membrane | 3.65e-01 | 1.00e+00 | 0.674 | 2 | 49 | 2582 |
GO:0008270 | zinc ion binding | 3.94e-01 | 1.00e+00 | 1.047 | 1 | 27 | 997 |
GO:0005739 | mitochondrion | 3.95e-01 | 1.00e+00 | 1.046 | 1 | 23 | 998 |
GO:0003677 | DNA binding | 4.61e-01 | 1.00e+00 | 0.758 | 1 | 49 | 1218 |
GO:0005524 | ATP binding | 4.83e-01 | 1.00e+00 | 0.667 | 1 | 31 | 1298 |
GO:0005730 | nucleolus | 5.71e-01 | 1.00e+00 | 0.328 | 1 | 66 | 1641 |